The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Therapeutic Vaccines-Global Market Insights and Sales Trends 2024
Synopsis
The global Therapeutic Vaccines market size is expected to reach US$ 117470 million by 2029, growing at a CAGR of 20.6% from 2023 to 2029. The market is mainly driven by the significant applications of Therapeutic Vaccines in various end use industries. The expanding demands from the Oncotherapy, Hepatitis B, Tuberculosis and Herpes Simplex Virus, are propelling Therapeutic Vaccines market. Peptide Therapeutic Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cell Therapeutic Vaccine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Therapeutic Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Therapeutic Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Therapeutic Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Therapeutic Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Therapeutic Vaccines covered in this report include Northeast Biotherapeutics, Agenus, Vaccinogen Inc, CIMAB S.A, Dendreon, Corixa and AVAX Technologies, etc.
The global Therapeutic Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Northeast Biotherapeutics
Agenus
Vaccinogen Inc
CIMAB S.A
Dendreon
Corixa
AVAX Technologies
Global Therapeutic Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Therapeutic Vaccines market, Segment by Type:
Peptide Therapeutic Vaccine
Cell Therapeutic Vaccine
Nucleic Acid Therapeutic Vaccine
Global Therapeutic Vaccines market, by Application
Oncotherapy
Hepatitis B
Tuberculosis
Herpes Simplex Virus
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Therapeutic Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Therapeutic Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Therapeutic Vaccines market size is expected to reach US$ 117470 million by 2029, growing at a CAGR of 20.6% from 2023 to 2029. The market is mainly driven by the significant applications of Therapeutic Vaccines in various end use industries. The expanding demands from the Oncotherapy, Hepatitis B, Tuberculosis and Herpes Simplex Virus, are propelling Therapeutic Vaccines market. Peptide Therapeutic Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cell Therapeutic Vaccine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Therapeutic Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Therapeutic Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Therapeutic Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Therapeutic Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Therapeutic Vaccines covered in this report include Northeast Biotherapeutics, Agenus, Vaccinogen Inc, CIMAB S.A, Dendreon, Corixa and AVAX Technologies, etc.
The global Therapeutic Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Northeast Biotherapeutics
Agenus
Vaccinogen Inc
CIMAB S.A
Dendreon
Corixa
AVAX Technologies
Global Therapeutic Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Therapeutic Vaccines market, Segment by Type:
Peptide Therapeutic Vaccine
Cell Therapeutic Vaccine
Nucleic Acid Therapeutic Vaccine
Global Therapeutic Vaccines market, by Application
Oncotherapy
Hepatitis B
Tuberculosis
Herpes Simplex Virus
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Therapeutic Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Therapeutic Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Therapeutic Vaccines Market Overview
1.1 Therapeutic Vaccines Product Overview
1.2 Therapeutic Vaccines Market Segment by Type
1.2.1 Peptide Therapeutic Vaccine
1.2.2 Cell Therapeutic Vaccine
1.2.3 Nucleic Acid Therapeutic Vaccine
1.3 Global Therapeutic Vaccines Market Size by Type
1.3.1 Global Therapeutic Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Therapeutic Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Therapeutic Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Therapeutic Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Therapeutic Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Therapeutic Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Therapeutic Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Therapeutic Vaccines Sales Breakdown by Type (2018-2023)
2 Global Therapeutic Vaccines Market Competition by Company
2.1 Global Top Players by Therapeutic Vaccines Sales (2018-2023)
2.2 Global Top Players by Therapeutic Vaccines Revenue (2018-2023)
2.3 Global Top Players by Therapeutic Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Therapeutic Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Therapeutic Vaccines Market Competitive Situation and Trends
2.5.1 Therapeutic Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Therapeutic Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Therapeutic Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Therapeutic Vaccines Market
2.8 Key Manufacturers Therapeutic Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Therapeutic Vaccines Status and Outlook by Region
3.1 Global Therapeutic Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Therapeutic Vaccines Historic Market Size by Region
3.2.1 Global Therapeutic Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Therapeutic Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Therapeutic Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Therapeutic Vaccines Forecasted Market Size by Region
3.3.1 Global Therapeutic Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Therapeutic Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Therapeutic Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Therapeutic Vaccines by Application
4.1 Therapeutic Vaccines Market Segment by Application
4.1.1 Oncotherapy
4.1.2 Hepatitis B
4.1.3 Tuberculosis
4.1.4 Herpes Simplex Virus
4.1.5 Others
4.2 Global Therapeutic Vaccines Market Size by Application
4.2.1 Global Therapeutic Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Therapeutic Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Therapeutic Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Therapeutic Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Therapeutic Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Therapeutic Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Therapeutic Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Therapeutic Vaccines Sales Breakdown by Application (2018-2023)
5 North America Therapeutic Vaccines by Country
5.1 North America Therapeutic Vaccines Historic Market Size by Country
5.1.1 North America Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Therapeutic Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Therapeutic Vaccines Sales in Value by Country (2018-2023)
5.2 North America Therapeutic Vaccines Forecasted Market Size by Country
5.2.1 North America Therapeutic Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Therapeutic Vaccines Sales in Value by Country (2024-2029)
6 Europe Therapeutic Vaccines by Country
6.1 Europe Therapeutic Vaccines Historic Market Size by Country
6.1.1 Europe Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Therapeutic Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Therapeutic Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Therapeutic Vaccines Forecasted Market Size by Country
6.2.1 Europe Therapeutic Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Therapeutic Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Therapeutic Vaccines by Region
7.1 Asia-Pacific Therapeutic Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Therapeutic Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Therapeutic Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Therapeutic Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Therapeutic Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Therapeutic Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Therapeutic Vaccines Sales in Value by Region (2024-2029)
8 Latin America Therapeutic Vaccines by Country
8.1 Latin America Therapeutic Vaccines Historic Market Size by Country
8.1.1 Latin America Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Therapeutic Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Therapeutic Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Therapeutic Vaccines Forecasted Market Size by Country
8.2.1 Latin America Therapeutic Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Therapeutic Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Therapeutic Vaccines by Country
9.1 Middle East and Africa Therapeutic Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Therapeutic Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Therapeutic Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Therapeutic Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Therapeutic Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Therapeutic Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Northeast Biotherapeutics
10.1.1 Northeast Biotherapeutics Company Information
10.1.2 Northeast Biotherapeutics Introduction and Business Overview
10.1.3 Northeast Biotherapeutics Therapeutic Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Northeast Biotherapeutics Therapeutic Vaccines Products Offered
10.1.5 Northeast Biotherapeutics Recent Development
10.2 Agenus
10.2.1 Agenus Company Information
10.2.2 Agenus Introduction and Business Overview
10.2.3 Agenus Therapeutic Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Agenus Therapeutic Vaccines Products Offered
10.2.5 Agenus Recent Development
10.3 Vaccinogen Inc
10.3.1 Vaccinogen Inc Company Information
10.3.2 Vaccinogen Inc Introduction and Business Overview
10.3.3 Vaccinogen Inc Therapeutic Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Vaccinogen Inc Therapeutic Vaccines Products Offered
10.3.5 Vaccinogen Inc Recent Development
10.4 CIMAB S.A
10.4.1 CIMAB S.A Company Information
10.4.2 CIMAB S.A Introduction and Business Overview
10.4.3 CIMAB S.A Therapeutic Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 CIMAB S.A Therapeutic Vaccines Products Offered
10.4.5 CIMAB S.A Recent Development
10.5 Dendreon
10.5.1 Dendreon Company Information
10.5.2 Dendreon Introduction and Business Overview
10.5.3 Dendreon Therapeutic Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Dendreon Therapeutic Vaccines Products Offered
10.5.5 Dendreon Recent Development
10.6 Corixa
10.6.1 Corixa Company Information
10.6.2 Corixa Introduction and Business Overview
10.6.3 Corixa Therapeutic Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Corixa Therapeutic Vaccines Products Offered
10.6.5 Corixa Recent Development
10.7 AVAX Technologies
10.7.1 AVAX Technologies Company Information
10.7.2 AVAX Technologies Introduction and Business Overview
10.7.3 AVAX Technologies Therapeutic Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 AVAX Technologies Therapeutic Vaccines Products Offered
10.7.5 AVAX Technologies Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Therapeutic Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Therapeutic Vaccines Industrial Chain Analysis
11.4 Therapeutic Vaccines Market Dynamics
11.4.1 Therapeutic Vaccines Industry Trends
11.4.2 Therapeutic Vaccines Market Drivers
11.4.3 Therapeutic Vaccines Market Challenges
11.4.4 Therapeutic Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Therapeutic Vaccines Distributors
12.3 Therapeutic Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
